Baillie Gifford & Co’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-284,058
| Closed | -$1.85M | – | 292 |
|
|
2024
Q2 | $1.85M | Sell |
284,058
-69,168
| -20% | -$451K | ﹤0.01% | 245 |
|
|
2024
Q1 | $2.93M | Sell |
353,226
-20,370
| -5% | -$169K | ﹤0.01% | 245 |
|
|
2023
Q4 | $4.11M | Sell |
373,596
-20,854
| -5% | -$230K | ﹤0.01% | 243 |
|
|
2023
Q3 | $3.32M | Sell |
394,450
-16,858
| -4% | -$142K | ﹤0.01% | 243 |
|
|
2023
Q2 | $5.17M | Sell |
411,308
-4,355
| -1% | -$54.7K | ﹤0.01% | 242 |
|
|
2023
Q1 | $6.85M | Buy |
415,663
+1,141
| +0.3% | +$18.8K | 0.01% | 235 |
|
|
2022
Q4 | $6.19M | Buy |
414,522
+9,902
| +2% | +$148K | 0.01% | 241 |
|
|
2022
Q3 | $9.05M | Buy |
404,620
+184,998
| +84% | +$4.14M | 0.01% | 222 |
|
|
2022
Q2 | $3.68M | Sell |
219,622
-24,655
| -10% | -$413K | ﹤0.01% | 249 |
|
|
2022
Q1 | $7.31M | Buy |
244,277
+19,236
| +9% | +$576K | 0.01% | 243 |
|
|
2021
Q4 | $6.91M | Buy |
225,041
+11,952
| +6% | +$367K | ﹤0.01% | 257 |
|
|
2021
Q3 | $6.72M | Buy |
213,089
+20,568
| +11% | +$648K | ﹤0.01% | 255 |
|
|
2021
Q2 | $7.04M | Buy |
192,521
+21,235
| +12% | +$777K | ﹤0.01% | 252 |
|
|
2021
Q1 | $5.92M | Buy |
171,286
+91,354
| +114% | +$3.16M | ﹤0.01% | 249 |
|
|
2020
Q4 | $3.32M | Sell |
79,932
-5,584,989
| -99% | -$232M | ﹤0.01% | 238 |
|
|
2020
Q3 | $42.5M | Buy |
+5,664,921
| New | +$42.5M | 0.03% | 159 |
|